Product Image

Contributor Information

  • Name Anne-Marie Mes-Masson and Diane Provencher
  • Institute Centre Hospitalier de L’université de Montréal
  • Primary citation Provencher et al. 2000. In Vitro Cell.Dev.Biol.-Animal (36): 357–361. PMID:10949994

Tool Details

  • Tool name: OV-90 cell line
  • Alternate names: OV-90
  • Tool type: Cell Lines
  • Organism: Human
  • Donor: Grade 3 – Stage IV; Mutations: TP53 Exon 6, CDKN2A Exon 2; Pre-treatment
  • Tissue: Derived from malignant ascites of a chemonaive ovarian cancer patient
  • Gender: Female
  • Cancer type: Gynaecologic cancer
  • CRISPR: No
  • Receptors of note: No
  • Description: Tumorigenic epithelial ovarian cancer cell line derived from malignant ascites of a patient never exposed to chemotherapy or radiation therapy. Cell line retains cahracteristics of the original epithelial ovarian cancers from which it was derived.
  • Research area: Cancer

  • For Research Use Only

Target Details

Application Details

Handling

Documentation

Related Tools

Product Image

R-3327 G cell line

#156408
Product Image

PC339C Cell line

#161810
Product Image

IVRO1 cell line

#161758

References

  • •  Raspaglio et al. 2023. Cancers (Basel). 18
  • •  15(8):2361. PMID: 37190289 Yee et al. 2022. Front Bioeng Biotechnol. 10
  • •  10:836984. PMID: 35223797 Brodeur et al. 2021. Sci Rep. 14
  • •  11(1):18183. PMID: 34521878 Buttarelli et al. 2022. J Exp Clin Cancer Res. 4
  • •  41(1):50. PMID: 35120576